MTOR and cancer: Biological examination of this synergistic interaction revealed increased endoplasmic reticulum stress in cancer cells, activation of autophagic cell death pathways, significant elevation of ROS levels, and suppression of the Phosphoinositide 3-kinase/Protein kinase B/mammalian Target of Rapamycin (PI3K/Akt/mTOR) pathway.